unknown
Stage
2017
Founded
1
Investors
About
Accure Therapeutics is an R&D pharmaceutical company developing medicines to treat central nervous system (CNS) disorders, focusing on neurodegeneration and neuroinflammation. The company is advancing clinical candidates (e.g., ACT-03) for indications such as Parkinson’s disease and post-traumatic epilepsy and has received public and foundation grants to support development.
Explore Accure Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.